Barclays’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Barclays’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-50,000	Closed	-$386K	–	7270
2016 Q4	$386K	Hold	50,000	–	–	﹤0.01%	3623
2016 Q3	$572K	Buy	+50,000	New	+$582K	﹤0.01%	3109

Barclays's OMED Position: Q2 2019 in Review

Barclays sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 66 shares.

Barclays first reported a position in OMED in Q3 2013 and held it in 23 quarters. The position peaked at $1.25M in Q2 2016. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Barclays reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Barclays sold 66 OncoMed Pharmaceuticals, Inc. shares in Q2 2019.
Barclays first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 23 quarters.
Barclays's OncoMed Pharmaceuticals, Inc. position peaked at $1.25M in Q2 2016.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.